Search Within

Raajit Kumar Rampal

Formats
  1. Meeting Abstract (191)
  2. Journal Article (123)
  3. Review (21)
  4. Research Letter (10)
  5. Book Section (2)
  6. Editorial (2)
  7. Guidelines (1)
  8. Miscellaneous (1)
Groups
  1. Adult Leukemia (351)
  2. Center for Hematologic Malignancies (351)
  3. Department of Medicine (351)
  4. Hematologic Malignancies, Division of (351)
  5. GSK Faculty (135)
  6. Executive Committee, Center for Hematologic Malignancies (131)

More Groups

People
  1. Ross Levine (87)
  2. Omar Abdel-Wahab (64)
  3. Martin Tallman (41)
  4. Eli Diamond (34)
  5. Ahmet Dogan (30)
  6. Minal Patel (29)

More People

Years
  1. 2025 (15)
  2. 2024 (35)
  3. 2023 (42)
  4. 2022 (36)
  5. 2021 (36)
  6. 2020 (26)

More Years

Publications
  1. Blood (148)
  2. Journal of Clinical Oncology (18)
  3. Blood Advances (15)
  4. Clinical Lymphoma, Myeloma and Leukemia (15)
  5. Haematologica (13)
  6. British Journal of Haematology (10)

More Publications

Publishers
  1. American Society of Hematology (164)
  2. Elsevier Inc. (24)
  3. Nature Publishing Group (22)
  4. American Society of Clinical Oncology (18)
  5. Ferrata Storti Foundation (13)
  6. American Association for Cancer Research (12)

More Publishers

Results (351)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The impact of pacritinib on myelofibrosis symptoms in patients with moderate and severe thrombocytopenia: A retrospective analysis of patients in the PERSIST-2 study
    Meeting Abstract

    Palmer, J. M.; Mesa, R. A.; Oh, S. T.; Rampal, R.; Buckley, S. A.; Roman-Torres, K.; Verstovsek, S.; Mascarenhas, J.; Vannucchi, A. M.; Kiladjian, J. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Safety analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia
    Meeting Abstract

    Mascarenhas, J.; Harrison, C. N.; Gerds, A. T.; Prchal, J. T.; Rampal, R.; Buckley, S. A.; Craig, A. R.; Smith, J. A.; Volpone, J.; Roman-Torres, K.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Treatment of myelofibrosis patients with the TGF-β 1/3 inhibitor AVID200 (MPN-RC 118) induces a profound effect on platelet production
    Meeting Abstract

    Mascarenhas, J.; Kosiorek, H. E.; Bhave, R.; Palmer, J. M.; Kuykendall, A. T.; Mesa, R. A.; Rampal, R.; Gerds, A. T.; Yacoub, A.; Pettit, K. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • HMGA1 chromatin regulators drive progression in myeloproliferative neoplasms through epigenetic rewiring to induce networks involved in GATA2 and proliferation
    Meeting Abstract

    Li, L.; Kim, J. H.; Lu, W.; Cope, L.; Williams, D. M.; Kim, J.; Rampal, R.; Koche, R.; Xian, L.; Luo, L.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • The BMP/SMAD pathway is a key mediator of leukemic transformation of TP53-mutant post-MPN AML
    Meeting Abstract

    Li, B.; An, W.; Wang, H.; Krishnan, A.; Mowla, S.; Baslan, T.; Koche, R.; Xiao, W.; Lowe, S.; Levine, R. L.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Pelabresib (CPI-0610) monotherapy in patients with myelofibrosis - Update of clinical and translational data from the ongoing MANIFEST trial
    Meeting Abstract

    Kremyanskaya, M.; Mascarenhas, J.; Palandri, F.; Vannucchi, A.; Verstovsek, S.; Harrison, C. N.; Bose, P.; Schiller, G. J.; Rampal, R.; Drummond, M. W.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • The High Mobility Group A1 chromatin regulator drives immune evasion during MPN progression by repressing genes involved in antigen presentation and immune attack
    Meeting Abstract

    Kim, J.; Kim, J. H.; Cope, L.; Li, L.; Rampal, R.; Koche, R.; Williams, D. M.; Spivak, J. L.; Moliterno, A. R.; Resar, L.
    Blood (2021)

    Fulltext@MSK | Save
  • MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
    Meeting Abstract

    Gigoux, M.; Zappasodi, R.; Park, J.; Bozkus, C. C.; Mangarin, L.; Redmond, D.; Verma, S.; Schad, S.; George, M.; Venkatesh, D.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • CPI-0610, a bromodomain and extraterminal domain (BET) protein inhibitor, in combination with ruxolitinib, in JAK-inhibitor-naïve myelofibrosis patients: Update of MANIFEST phase 2 study
    Meeting Abstract

    Platzbecker, U.; Mascarenhas, J.; Harrison, C.; Patriarca, A.; Devos, T.; Palandri, F.; Rampal, R.; Vannucchi, A.; Mead, A.; Kremyanskaya, M.; more...
    Oncology Research and Treatment (2021)

    Fulltext@MSK | Save
  • Extramedullary hematopoiesis in myeloproliferative neoplasms: Pathophysiology and treatment strategies
    Review

    Chernak, B. J.; Rampal, R. K.
    International Review of Cell and Molecular Biology (2021)

    Fulltext@MSK | Save